Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases

por Jansen, Yanina J L, Verset, Gontran, Schats, Kelly, Van Dam, Pieter-Jan, Seremet, Teofila, Kockx, Mark, Van Laethem, Jean-Luc B, Neyns, Bart
Publicado 2019

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients

por Seremet, Teofila, Koch, Alexander, Jansen, Yanina, Schreuer, Max, Wilgenhof, Sofie, Del Marmol, Véronique, Liènard, Danielle, Thielemans, Kris, Schats, Kelly, Kockx, Mark, Van Criekinge, Wim, Coulie, Pierre G., De Meyer, Tim, van Baren, Nicolas, Neyns, Bart
Publicado 2016

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab

por Awada, Gil, Jansen, Yanina, Schwarze, Julia Katharina, Tijtgat, Jens, Hellinckx, Lennert, Gondry, Odrade, Vermeulen, Sim, Warren, Sarah, Schats, Kelly, van Dam, Pieter-Jan, Kockx, Mark, Keyaerts, Marleen, Everaert, Hendrik, Seremet, Teofila, Rogiers, Anne, Neyns, Bart
Publicado 2021